Compare with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES PANACEA BIOTECH ALKEM LABORATORIES/
PANACEA BIOTECH
 
P/E (TTM) x 22.0 9.1 242.4% View Chart
P/BV x 5.3 3.5 150.1% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 ALKEM LABORATORIES   PANACEA BIOTECH
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-20
PANACEA BIOTECH
Mar-19
ALKEM LABORATORIES/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs2,720354 769.2%   
Low Rs1,660138 1,201.4%   
Sales per share (Unadj.) Rs697.974.6 935.9%  
Earnings per share (Unadj.) Rs96.16.7 1,439.1%  
Cash flow per share (Unadj.) Rs117.315.5 756.7%  
Dividends per share (Unadj.) Rs25.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs515.257.2 900.6%  
Shares outstanding (eoy) m119.5761.25 195.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.13.3 95.2%   
Avg P/E ratio x22.836.8 61.9%  
P/CF ratio (eoy) x18.715.9 117.7%  
Price / Book Value ratio x4.34.3 98.9%  
Dividend payout %26.00-   
Avg Mkt Cap Rs m261,87915,061 1,738.7%   
No. of employees `00014.32.3 619.3%   
Total wages/salary Rs m15,0551,471 1,023.6%   
Avg. sales/employee Rs Th5,822.61,973.6 295.0%   
Avg. wages/employee Rs Th1,050.5635.6 165.3%   
Avg. net profit/employee Rs Th802.0176.8 453.6%   
INCOME DATA
Net Sales Rs m83,4444,567 1,827.1%  
Other income Rs m1,04245 2,326.3%   
Total revenues Rs m84,4864,612 1,831.9%   
Gross profit Rs m14,7342,030 725.9%  
Depreciation Rs m2,528540 468.1%   
Interest Rs m6511,048 62.1%   
Profit before tax Rs m12,598486 2,591.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,10577 1,432.9%   
Profit after tax Rs m11,493409 2,809.4%  
Gross profit margin %17.744.4 39.7%  
Effective tax rate %8.815.9 55.3%   
Net profit margin %13.89.0 153.8%  
BALANCE SHEET DATA
Current assets Rs m54,9602,415 2,276.3%   
Current liabilities Rs m32,4339,077 357.3%   
Net working cap to sales %27.0-145.9 -18.5%  
Current ratio x1.70.3 637.1%  
Inventory Days Days8065 122.2%  
Debtors Days Days7271 101.7%  
Net fixed assets Rs m32,7108,333 392.5%   
Share capital Rs m23961 390.0%   
"Free" reserves Rs m61,3683,443 1,782.5%   
Net worth Rs m61,6073,504 1,758.2%   
Long term debt Rs m1,592461 345.3%   
Total assets Rs m99,43313,755 722.9%  
Interest coverage x20.41.5 1,391.1%   
Debt to equity ratio x00.1 19.6%  
Sales to assets ratio x0.80.3 252.8%   
Return on assets %12.210.6 115.3%  
Return on equity %18.711.7 159.8%  
Return on capital %21.038.7 54.2%  
Exports to sales %19.120.9 91.3%   
Imports to sales %3.08.1 36.5%   
Exports (fob) Rs m15,917954 1,668.6%   
Imports (cif) Rs m2,483372 667.6%   
Fx inflow Rs m16,0611,203 1,335.1%   
Fx outflow Rs m2,483467 532.1%   
Net fx Rs m13,578736 1,844.0%   
CASH FLOW
From Operations Rs m5,8511,049 557.9%  
From Investments Rs m-7,414-54 13,857.0%  
From Financial Activity Rs m792-1,011 -78.3%  
Net Cashflow Rs m-731-20 3,711.2%  

Share Holding

Indian Promoters % 66.9 74.5 89.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 0.6 5,516.7%  
FIIs % 0.0 1.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 23.6 -  
Shareholders   68,381 10,259 666.5%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   IPCA LABS  SANOFI INDIA  DR. DATSONS LABS  PROCTER & GAMBLE HEALTH  NOVARTIS  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

SGX Nifty Trades 279 Points Lower; Indicates Gap-Down Opening for Indian Stock Markets(SGX Nifty)

The SGX Nifty opened on a negative note today. At 8:10 am, it was trading down by 279 points, or 1.9% lower at 14,900 levels.

Related Views on News

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

More Views on News

Most Popular

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Feb 26, 2021 09:32 AM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS